Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)

Affiliations

• ¹ Clinical Oncology, University of Oxford, Oxford, UK.
• ² Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
• ³ Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
• ⁴ Paediatric Oncology, Children's Hospital for Wales, Cardiff, UK.
• ⁵ Paediatric Oncology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
• ⁶ Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
• ⁷ Clinical Oncology, The Royal Marsden NHS Foundation Trust, Surrey, UK.
• ⁸ Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
• ⁹ Paediatric Oncology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
• ¹⁰ Paediatric Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
• ¹¹ Paediatric Oncology, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.
• ¹² Paediatric Oncology, Nottingham Children's Hospital University of Nottingham, Nottingham, UK.
• ¹³ Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
• ¹⁴ Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
• ¹⁵ Clinical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
• ¹⁶ Paediatric Oncology, The Leeds Teaching Hospitals, Leeds, UK.
• ¹⁷ Cancer Research Unit, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
• ¹⁸ Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.